NCS Multistage (NASDAQ:NCSM - Get Free Report) released its earnings results on Monday. The company reported $2.27 EPS for the quarter, beating the consensus estimate of $0.83 by $1.44, Zacks reports. NCS Multistage had a return on equity of 2.60% and a net margin of 27.99%. The firm had revenue of $45.00 million during the quarter, compared to analyst estimates of $40.60 million.
NCS Multistage Trading Down 0.5 %
Shares of NCSM stock traded down $0.13 during trading hours on Friday, hitting $27.87. 7,857 shares of the company were exchanged, compared to its average volume of 6,138. The firm has a fifty day moving average of $28.40 and a 200 day moving average of $24.05. The company has a quick ratio of 2.63, a current ratio of 4.50 and a debt-to-equity ratio of 0.06. NCS Multistage has a 1 year low of $15.20 and a 1 year high of $31.82. The firm has a market cap of $69.76 million, a PE ratio of 1.64 and a beta of 1.05.
NCS Multistage Company Profile
(
Get Free Report)
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.
Recommended Stories
Before you consider NCS Multistage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NCS Multistage wasn't on the list.
While NCS Multistage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
